Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: re: ``Even if they split the profits of 200 Billion a year one hundred billion for PTSC is not bad,

re: ``Even if they split the profits of 200 Billion a year one hundred billion for PTSC is not bad,

posted on Jun 09, 2006 11:14PM
The only problem with your senario is that so far all our licensing deals have been a one time fee with no recurring

revenues. Not a yearly fee, a one time fee.

Share
New Message
Please login to post a reply